Adoptive immunotherapy in BALB-c times DBA-2 Cr F1 mice bearing an immunogenic subline of L1210 leukemia.
D000577:Amides / Q000494:pharmacology; D000818:Animals; D007093:Imidazoles / Q000494:pharmacology*; D007111:Immunity, Cellular; D007112:Immunity, Maternally-Acquired; D007116:Immunization, Passive; D007939:Leukemia L1210 / Q000276:immunology / Q000628:therapy*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D013154:Spleen / Q000276:immunology*; D014226:Triazenes / Q000494:pharmacology*
D000577:Amides; D007093:Imidazoles; D014226:Triazenes